Roche Holding AG (TSX:ROG) FFO


TSX:ROG Roche Holding AG TSX:ROG
57 GF Score
Price C$26.30
GF Value C$20.84
Valuation Modestly Overvalued
! 3 Warning Signs
View Full Analysis

What is Roche Holding AG FFO?

FFO (Funds from operations) only applies to REITs.

TSX:ROG
57GF Score
Roche Holding AG TSX:ROG
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Roche Holding AG (TSX:ROG) Overvalued in 2026?

Based on GuruFocus' analysis, Roche Holding AG stock appears to be overvalued. The current stock price of C$26.30 is trading 26.2% above its estimated GF Value™ of C$20.84. GuruFocus considers Roche Holding AG to be Modestly Overvalued.

Key valuation signals for TSX:ROG:

  • FFO:
  • GF Value™: C$20.84 vs. price of C$26.30 (26.2% above fair value)
  • GF Score™: 57/100 with 3 warning signs

No single metric tells the full story. See the TSX:ROG stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Roche Holding AG Business Description

Address Grenzacherstrasse 124, Basel, CHE, 4070
Roche is a Swiss biopharmaceutical and diagnostic company. The firm's bestselling pharmaceutical products include a variety of oncology therapies from acquired partner Genentech, and its diagnostics group was bolstered by the acquisition of Ventana in 2008. Oncology products account for 40% of pharmaceutical sales, and centralized and point-of-care diagnostics for two-thirds of diagnostic-related sales.
57GF Score

Get the complete analysis for TSX:ROG

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

C$26.30
Price
C$20.84
GF Value